Evercore Issues Positive Forecast for Humana (NYSE:HUM) Stock Price

Humana (NYSE:HUM) had its price target increased by equities research analysts at Evercore from $250.00 to $370.00 in a research note issued to investors on Thursday,MarketScreener reports. Evercore’s price target indicates a potential downside of 0.07% from the stock’s current price.

Several other equities research analysts have also recently commented on the company. Leerink Partners upped their price target on Humana from $185.00 to $255.00 and gave the stock a “market perform” rating in a research note on Thursday, April 30th. Mizuho upped their price objective on shares of Humana from $335.00 to $390.00 and gave the stock an “outperform” rating in a research report on Monday. Wells Fargo & Company cut shares of Humana from a “cautious” rating to a “reduce” rating in a research note on Wednesday, May 20th. Royal Bank Of Canada reaffirmed a “sector perform” rating on shares of Humana in a report on Monday, June 1st. Finally, Cantor Fitzgerald assumed coverage on shares of Humana in a research note on Wednesday, May 20th. They set an “overweight” rating on the stock. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, fifteen have assigned a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat, Humana has an average rating of “Hold” and a consensus target price of $291.35.

Humana Stock Performance

Shares of HUM stock traded up $5.79 during mid-day trading on Thursday, hitting $370.25. 113,094 shares of the stock were exchanged, compared to its average volume of 1,882,474. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The stock has a market capitalization of $44.45 billion, a price-to-earnings ratio of 39.60, a P/E/G ratio of 2.08 and a beta of 0.76. The stock’s fifty day simple moving average is $259.94 and its two-hundred day simple moving average is $235.20. Humana has a 12-month low of $163.11 and a 12-month high of $370.00.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. During the same quarter in the previous year, the firm posted $11.58 EPS. The firm’s revenue for the quarter was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. On average, analysts forecast that Humana will post 9 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Capital International Investors boosted its stake in shares of Humana by 113.9% during the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after acquiring an additional 3,097,571 shares in the last quarter. Norges Bank purchased a new position in Humana in the 4th quarter valued at approximately $456,632,000. Pzena Investment Management LLC raised its holdings in Humana by 34.3% during the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after purchasing an additional 1,398,774 shares during the last quarter. Wellington Management Group LLP raised its holdings in Humana by 4,481.7% during the fourth quarter. Wellington Management Group LLP now owns 1,196,502 shares of the insurance provider’s stock worth $306,460,000 after purchasing an additional 1,170,387 shares during the last quarter. Finally, Franklin Resources Inc. boosted its position in Humana by 914.5% during the fourth quarter. Franklin Resources Inc. now owns 1,255,665 shares of the insurance provider’s stock worth $321,613,000 after purchasing an additional 1,131,893 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.